首页 > 市场调查报告书 > 医疗设备

医院 IT 人工智能

市场调查报告书

商品编码

1606544

全球心理健康与治疗市场聊天机器人 - 2024-2031

Global Chatbots for mental health and therapy Market - 2024-2031

出版日期: 2024年12月04日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2023 年，全球心理健康和治疗聊天机器人市场规模达到 11 亿美元，预计到 2031 年将达到 17.6 亿美元，2024-2031 年预测期间复合年增长率为 6.2%。

治疗聊天机器人，也称为心理健康聊天机器人，是先进的对话式人工智慧系统，旨在帮助个人管理其心理健康。这些聊天机器人利用自然语言处理 (NLP) 和机器学习等技术，让使用者参与有意义的对话，评估他们的心理健康状况，并提供个人化的应对策略或资源。它们可以透过各种平台访问，包括行动应用程式、网站和讯息应用程式。

用于心理健康和治疗的聊天机器人是人工智慧驱动的工具，旨在模拟类人对话，为使用者提供心理支持和资源。这些聊天机器人结合了基于证据的治疗技术，例如认知行为疗法（CBT），以帮助个人管理其心理健康。透过提供即时反应和支持，他们成为寻求帮助的人的第一个接触点，特别是在传统心理健康服务可能受到限製或受到侮辱的地区。这些因素推动了全球聊天机器人在心理健康和治疗市场的扩张。

市场动态：

驱动程式和限制

无障碍心理健康服务的需求不断增加

对无障碍心理健康服务的需求不断增长，极大地推动了全球心理健康和治疗市场聊天机器人的成长，预计将在整个市场预测期内推动成长。

根据世界卫生组织 (WHO) 报告，这场大流行深刻影响了全球心理健康，导致全球焦虑和忧郁症发病率增加了 25%。这段时间经历的孤立、对疾病的恐惧、经济不稳定和悲伤加剧了现有的心理健康问题并引入了新的问题。

传统的精神健康服务经常遇到重大障碍，例如预约等待时间长、专业人员有限以及地理限制。由于这些挑战，许多人不愿寻求帮助。聊天机器人透过随时提供即时支援和资源来提供可行的替代方案。

此外，产业研究的主要参与者将推动全球聊天机器人促进心理健康和治疗市场的成长。这项有效性这项研究涉及英格兰 28 个 NHS 谈话治疗服务的 129,400 名患者，并证明人工智慧的使用可以显着提高获得心理健康支持的机会，特别是对于代表性不足的群体。研究发现，非二元性别个体获得心理健康支持的机会显着增加了 179%。少数族裔群体的使用率也增加了 29%。这表明边缘系统有效地涵盖了历史上在获得心理健康服务方面面临障碍的人。

同样，根据《柳叶刀》2021 年 10 月的一篇文章，疫情对全球心理健康产生了深远影响，在全球范围内引发了约 7,600 万例焦虑症和 5,300 万例忧郁症。精神健康疾病的惊人增加可归因于与疫情造成的社会、经济和健康相关破坏相关的几个因素。所有这些因素都需要全球聊天机器人来开拓心理健康和治疗市场。

此外，该行业的主要参与者产品发布和投资将推动这些全球聊天机器人促进心理健康和治疗市场的成长。例如，2023年1月，Limbic Inc.推出了Limbic Access，这是一种创新的心理健康评估工具，旨在提高心理治疗的效率和效果。 Limbic Access 是一款由人工智慧驱动的聊天机器人，专注于为寻求心理健康援助的个人提供安全、临床有效和风险管理的支援。

此外，2023 年 10 月，BeMeHealth 宣布了一位新的策略投资者，将支持其成长和扩张工作。这项投资将使 BeMeHealth 能够增强其产品，可能会纳入旨在改善心理健康护理的更先进的技术或服务。资本的涌入可能会让 BeMeHealth 开发新功能或将业务范围扩大到服务不足的市场，从而增加其对精神健康保健服务的影响。所有这些因素都需要全球聊天机器人来开拓心理健康和治疗市场。

此外，与数位健康平台的整合有助于全球聊天机器人扩大心理健康和治疗市场。

隐私和资料安全问题

隐私和资料安全问题将阻碍全球心理健康和治疗市场聊天机器人的成长。

心理健康聊天机器人通常要求用户透露敏感的个人讯息，例如有关其心理健康状况、情绪状态和个人历史的详细资讯。鑑于这些资料的私密性，用户可能担心它可能会被揭露或滥用。与共享此类资讯相关的漏洞增加了隐私方面的风险。

儘管信誉良好的聊天机器人提供者实施了强有力的安全措施，但资料外洩的风险仍然是一个主要问题。网路安全威胁非常普遍，敏感资料可能会因骇客攻击或未经授权的存取而受到损害。此类违规行为可能会给用户带来严重的影响，包括情绪困扰，如果他们的私人资讯被公开，可能会带来潜在的耻辱。

根据 A Vinove 公司 2024 年的资料，表示在透过 AI 聊天机器人处理敏感的心理健康资讯时，会出现重大的隐私问题。必须确保所有互动都经过加密和安全存储，并符合 GDPR 和 HIPAA 等法规。儘管聊天机器人可以非常有效地提供支持，但它们通常很难掌握人类情感的全部复杂性。在更复杂的情况下，这种限制可能会导致误解或回应不足。

许多心理健康聊天机器人不会传达用户资料的收集、储存或使用方式。用户可能不知道他们的资料是否与第三方共享，例如广告商或健康保险公司。缺乏透明度可能会破坏对这些平台的信任，因为个人可能担心他们的资讯如何处理以及它是否符合他们对保密的期望。

因此，上述因素可能会限制全球心理健康和治疗市场聊天机器人的潜在成长。

Therapy chatbots, also referred to as mental health chatbots, are advanced conversational AI systems designed to assist individuals in managing their mental well-being. These chatbots leverage technologies such as natural language processing (NLP) and machine learning to engage users in meaningful conversations, assess their mental health status, and provide personalized coping strategies or resources. They can be accessed through various platforms, including mobile applications, websites, and messaging apps.

Chatbots for mental health and therapy are AI-driven tools designed to simulate human-like conversations, providing psychological support and resources to users. These chatbots incorporate evidence-based therapeutic techniques, such as Cognitive Behavioral Therapy (CBT), to assist individuals in managing their mental health. By offering immediate responses and support, they serve as accessible first points of contact for those seeking help, especially in areas where traditional mental health services may be limited or stigmatized. These factors have driven the global chatbots for mental health and therapy market expansion.

Market Dynamics: Drivers & Restraints

Increasing Demand for Accessible Mental Health Services

The increasing demand for accessible mental health services is significantly driving the growth of the global chatbots for mental health and therapy market and is expected to drive throughout the market forecast period.

The pandemic has profoundly affected global mental health, resulting in a 25% increase in anxiety and depression rates worldwide, as reported by the World Health Organization (WHO). The isolation, fear of illness, financial instability, and grief experienced during this time have exacerbated existing mental health issues and introduced new ones.

Traditional mental health services often encounter significant obstacles, such as long wait times for appointments, limited availability of professionals, and geographic constraints. Many individuals are discouraged from seeking help due to these challenges. Chatbots offer a viable alternative by providing immediate support and resources at any time.

Furthermore, key players in the industry research studies that would drive the global chatbots for mental health and therapy market growth.For instnace, in January 2023, a significant study was published that highlighted the effectiveness of Limbic Access, an AI-powered mental health assessment tool developed by Limbic Inc. This research involved 129,400 patients across 28 NHS Talking Therapies services in England and demonstrated that the use of AI can significantly enhance access to mental health support, particularly for underrepresented groups. The study found a remarkable 179% increase in access to mental health support among non-binary individuals. There was also a 29% increase in access among ethnic minority groups. This indicates that Limbic Access effectively reached demographics that have historically faced barriers to accessing mental health services.

Similarly, according to a publication in The Lancet in October 2021, the pandemic had a profound impact on global mental health, triggering approximately 76 million cases of anxiety and 53 million cases of depression worldwide. This staggering increase in mental health disorders can be attributed to several factors associated with the pandemic's social, economic, and health-related disruptions. All these factors demand the global chatbots for mental health and therapy market.

Additionally, key players in the industry product launches and investments that would drive these global chatbots for mental health and therapy market growth. For instance, in January 2023, Limbic Inc. launched Limbic Access, an innovative mental health assessment tool designed to enhance the efficiency and effectiveness of psychological therapies. Limbic Access is an AI-powered chatbot that focuses on providing secure, clinically effective, and risk-managed support for individuals seeking mental health assistance.

Also, in October 2023, BeMeHealth announced a new strategic investor that will support its growth and expansion efforts. The investment will enable BeMeHealth to enhance its offerings, likely incorporating more advanced technologies or services aimed at improving mental health care. The influx of capital may allow BeMeHealth to develop new features or expand its reach into underserved markets, thereby increasing its impact on mental health care delivery. All these factors demand the global chatbots for mental health and therapy market.

Moreover, the Integration with Digital Health Platforms contributes to the global chatbots for mental health and therapy market expansion.

Privacy and Data Security Concerns

The privacy and data security concerns will hinder the growth of the global chatbots for mental health and therapy market.

Mental health chatbots often require users to disclose sensitive personal information, such as details about their mental health conditions, emotional states, and personal histories. Given the private nature of this data, users may fear that it could be exposed or misused. The vulnerability associated with sharing such information increases the stakes surrounding privacy.

Despite the implementation of strong security measures by reputable chatbot providers, the risk of data breaches remains a major concern. Cybersecurity threats are widespread, and sensitive data could potentially be compromised through hacking or unauthorized access. Such breaches can lead to severe repercussions for users, including emotional distress and potential stigma if their private information is made public.

According to the A Vinove Company data in 2024, stated that when dealing with sensitive mental health information through AI chatbots, significant privacy concerns arise. It is essential to ensure that all interactions are encrypted and securely stored, as well as compliant with regulations such as GDPR and HIPAA. Although chatbots can be very effective in offering support, they often struggle to grasp the full complexity of human emotions. This limitation can result in misunderstandings or inadequate responses in more complicated situations.

Many mental health chatbots do not communicate how user data is collected, stored, or utilized. Users may be unaware if their data is shared with third parties, such as advertisers or health insurance companies. This lack of transparency can undermine trust in these platforms, as individuals may worry about how their information is handled and whether it aligns with their expectations for confidentiality.

Thus, the above factors could be limiting the global chatbots for mental health and therapy market's potential growth.

Segment Analysis

The global chatbots for mental health and therapy market is segmented based on technology, component, application, and region.

Technology:

The natural language processing (NLP) segment is expected to dominate the global chatbots for mental health and therapy market share

The natural language processing (NLP) segment holds a major portion of the global chatbots for mental health and therapy market share and is expected to continue to hold a significant portion of the global chatbots for mental health and therapy market share during the forecast period.

Natural Language Processing (NLP) equips chatbots with the ability to analyze and interpret the complexities of human language, allowing for more natural and empathetic conversations. This capability is vital for fostering a supportive environment where users feel heard and validated. By incorporating sentiment analysis, chatbots can assess the emotional tone of user interactions. This functionality enables them to respond appropriately, offering empathy and customized support based on the user's emotional state, which is crucial in mental health scenarios.

According to the Springer Nature research publication in October 2023, neuropsychiatric disorders impose a significant societal burden, but their treatment is complicated by the absence of objective outcomes and fidelity metrics. Artificial intelligence technologies, particularly Natural Language Processing (NLP), have emerged as valuable tools for analyzing mental health interventions (MHI) by examining the conversations that comprise them.

Natural Language Processing (NLP) enhances a chatbot's ability to maintain contextual awareness throughout interactions. By recalling previous conversations and referencing them, chatbots can offer more personalized and relevant assistance over time, thereby improving user engagement and satisfaction. The application of NLP allows chatbots to tailor responses according to individual user preferences and needs. This personalization may involve adjusting the communication style or providing specific mental health resources that resonate with the user's situation.

The integration of machine learning models with NLP enables chatbots to continually refine their responses based on user interactions and feedback. This ongoing learning process enhances the chatbot's adaptability to changing language patterns and individual user requirements. These factors have solidified the segment's position in the global chatbots for mental health and therapy market.

Geographical Analysis

North America is expected to hold a significant position in the global chatbots for mental health and therapy market share

North America holds a substantial position in the global chatbots for mental health and therapy market and is expected to hold most of the market share.

The region has a considerable number of individuals suffering from mental health issues such as depression, anxiety, and stress-related disorders. This widespread prevalence creates a robust demand for accessible mental health services, driving the adoption of innovative solutions like chatbots.

North America features a well-established healthcare infrastructure that supports the integration of digital health technologies. The availability of advanced technological resources facilitates the effective deployment of AI-driven solutions, including chatbots, making them more efficient and widely accessible.

There is a strong focus on leveraging technology to enhance mental health care delivery in North America. Companies are investing significantly in developing sophisticated chatbots that utilize advanced Natural Language Processing (NLP) and machine learning techniques to improve user interactions and therapeutic outcomes.

Furthermore, in this region, a major number of key players' presence, government initiatives & regulatory support, and product launches would propel these global chatbots for mental health and therapy market growth. For instance, in November 2024, Jimini Health, a digital health startup, launched its services with $8 million in pre-seed funding aimed at transforming mental healthcare through a unique clinician-led therapy model augmented by responsible artificial intelligence (AI). The funding round saw participation from notable investors including Zetta Venture Partners, LionBird, PsyMed, BoxGroup, Arkitekt Ventures, and SCB.

Also, in March 2023, Botpress, launched the industry's first visual builder tool that enables users to create advanced chatbots capable of executing complex workflows on top of ChatGPT in just a matter of minutes in Canada. This innovation is designed to democratize chatbot creation, making it accessible to a wider range of users, including those without extensive programming knowledge. Users can develop customized personal assistants, educational bots, coding assistants, social service hotlines, mental health support bots, smart email responders, and life coaching guides.

Thus, the above factors are consolidating the region's position as a dominant force in the global chatbots for mental health and therapy market.

Asia Pacific is growing at the fastest pace in the global chatbots for mental health and therapy market share

Asia Pacific holds the fastest pace in the global chatbots for mental health and therapy market and is expected to hold most of the market share.

In Asia-Pacific region is experiencing an increase in mental health issues, including anxiety, depression, and stress-related disorders. This growing prevalence creates a strong demand for accessible mental health services, which chatbots can effectively provide.

According to the National Center for Biotechnology Information (NCBI) research publication in July 2023, in India, mental health disorders are highly prevalent, affecting a significant portion of the population. Epidemiological studies indicate that the prevalence rates for psychiatric disorders range from 9.5 to 370 per 1,000 individuals. This wide range reflects the diverse challenges faced by individuals in the country. The high prevalence of mental health disorders underscores the urgent need for effective interventions and support systems to enhance the mental well-being of the population. Commonly observed conditions include depression, anxiety disorders, bipolar disorder, schizophrenia, and substance use disorders.

Rapid urbanization in countries such as China and India is leading to lifestyle changes that often contribute to heightened stress and mental health challenges. As urban populations expand, there is a corresponding rise in the demand for convenient mental health solutions like chatbots. The proliferation of smartphones and internet connectivity in the Asia-Pacific region facilitates the use of digital health solutions. Chatbots, accessible via mobile devices, are becoming increasingly popular among individuals seeking immediate mental health support.

Furthermore, in this region, key player's initiatives, such as partnerships & collaborations, and product launches would drive the global healthcare chatbots market growth. For instance, in June 2023, the Osmania Technology Business Incubator (OTBI) in collaboration with Findhope, took place at Osmania University. This event provided a unique platform for students to engage in discussions centered around mental well-being and contribute innovative ideas aimed at enhancing Findhope's AI WhatsApp chatbot.

Also, in April 2024, Wysa, launched a Hindi version of its conversational AI therapy app, aiming to enhance the accessibility of quality mental health services in underserved communities across India, particularly in Tier II and III cities. This initiative addresses significant barriers to mental health care in regions where access to traditional therapy is limited.

Similarly, in July 2023, Jammu and Kashmir (J&K) launched India's first Tele-MANAS chatbot, designed to provide immediate support for individuals in mental distress. This initiative aims to enhance mental health services in the region by ensuring round-the-clock access to health counselors, clinical psychologists, and consultants.

Also, in April 2024, the Chinese University of Hong Kong (CUHK) launched an AI chatbot aimed at providing mental health support to the youth in Hong Kong, particularly in response to the increasing demand for mental health services and the growing complexity of cases among students. This initiative is part of the Jockey Club TourHeart+ project, which has been enhanced by a donation from the Hong Kong Jockey Club.

Thus, the above factors are consolidating the region's position as the fastest-growing force in the global chatbots for mental health and therapy market.

Competitive Landscape

The major global players in the chatbots for mental health and therapy market include Woebot Health, Wysa Ltd, Youper Inc., X2ai Inc., Quartet Health, Headspace Health, Marigold Health, BioBeats, Lyra Health, Inc., and Limbic among others.

Key Developments

In November 2024, Rogers Behavioral Health announced a partnership with Limbic Inc. to implement an AI chatbot, Limbic Access, aimed at transforming its patient intake process. This initiative marks a significant shift from the traditional phone-based intake system to a more modern, AI-driven approach that enhances accessibility and efficiency in mental health care.
In November 2024, HealthSci.AI launched an innovative suite of health-focused and biotech-driven chatbots designed to empower users with personalized guidance and support across a wide range of health and biotechnology topics. This initiative aims to provide an accessible pathway for users to proactively manage their health and navigate the complexities of biotechnology with confidence.
In June 2024, Sonia is a newly launched AI chatbot designed to provide a convenient and accessible alternative to traditional therapy. Developed by a startup of the same name, Sonia utilizes multiple generative AI models to analyze user interactions during therapy sessions conducted through the app, allowing it to respond appropriately to users' needs. Sonia is designed to address a wide range of mental health challenges, including depression, stress, anxiety, relationship issues, and sleep disturbances. This broad focus allows it to cater to diverse user needs.
In April 2024, Fortis Healthcare launched Adayu Mindfulness, an AI-powered chatbot designed to provide mental health support for individuals facing psychological challenges. This innovative application serves as a digital-first aid kit for mental health, particularly targeting those who may be hesitant to seek professional help due to societal stigma surrounding mental health issues.
In January 2024, the GPT Store launched by OpenAI, is a groundbreaking platform that allows users to buy and sell custom AI chatbots, including those designed for mental health support. This store has generated significant interest due to its diverse offerings, which range from highly effective and serious applications to more unconventional or "wacko" chatbots.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global chatbots for mental health and therapy market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Technology
3.2. Snippet by Component
3.3. Snippet by Application
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Demand for Accessible Mental Health Services
- 4.1.2. Restraints
  - 4.1.2.1. Privacy and Data Security Concerns
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. Regulatory Analysis
5.6. SWOT Analysis
5.7. Unmet Needs

6. By Technology

6.1. Introduction
- 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Technology
- 6.1.2. Market Attractiveness Index, By Technology
6.2. Natural Language Processing (NLP)*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Machine Learning (ML)
6.4. Others

7. By Component

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 7.1.2. Market Attractiveness Index, By Component
7.2. Software*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Services

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Symptom Assessment*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Therapeutic Support
8.4. Crisis Management
8.5. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. U.K.
  - 9.3.6.3. France
  - 9.3.6.4. Spain
  - 9.3.6.5. Italy
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Woebot Health *
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Wysa Ltd
11.3. Youper Inc.
11.4. X2ai Inc.
11.5. Quartet Health
11.6. Headspace Health
11.7. Marigold Health
11.8. BioBeats
11.9. Lyra Health, Inc.
11.10. Limbic (LIST NOT EXHAUSTIVE)